Vaskar Saha

7.1k total citations
142 papers, 4.0k citations indexed

About

Vaskar Saha is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Vaskar Saha has authored 142 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Public Health, Environmental and Occupational Health, 47 papers in Hematology and 41 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Vaskar Saha's work include Acute Lymphoblastic Leukemia research (72 papers), Childhood Cancer Survivors' Quality of Life (38 papers) and Acute Myeloid Leukemia Research (28 papers). Vaskar Saha is often cited by papers focused on Acute Lymphoblastic Leukemia research (72 papers), Childhood Cancer Survivors' Quality of Life (38 papers) and Acute Myeloid Leukemia Research (28 papers). Vaskar Saha collaborates with scholars based in United Kingdom, India and Germany. Vaskar Saha's co-authors include Andrea Biondi, Tracy Chaplin, Bryan D. Young, Giovanni Cazzaniga, Shekhar Krishnan, O B Eden, Maria Daniotti, G. M. Addison, Giuseppe Masera and J. Wiemels and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Vaskar Saha

137 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Vaskar Saha 2.2k 1.6k 1.2k 1.1k 709 142 4.0k
Allen Eng Juh Yeoh 1.7k 0.8× 1.3k 0.8× 1.6k 1.3× 1.0k 1.0× 608 0.9× 108 3.9k
Alan S. Gamis 1.7k 0.8× 3.1k 1.9× 1.6k 1.4× 696 0.7× 1.1k 1.6× 222 5.0k
F Zintl 1.2k 0.6× 1.2k 0.7× 1.2k 1.0× 784 0.7× 1.3k 1.9× 161 4.1k
Joseph Mirro 2.0k 0.9× 2.7k 1.7× 1.2k 1.1× 497 0.5× 822 1.2× 93 4.7k
Yves Chalandon 1.4k 0.6× 2.3k 1.4× 494 0.4× 623 0.6× 995 1.4× 192 4.3k
Ursula Creutzig 3.0k 1.4× 5.2k 3.2× 2.5k 2.2× 812 0.8× 1.8k 2.5× 217 7.6k
Alix E. Seif 836 0.4× 804 0.5× 520 0.4× 548 0.5× 1.4k 1.9× 122 3.1k
Nicholas J. Short 2.7k 1.2× 4.4k 2.7× 2.0k 1.7× 580 0.6× 1.7k 2.4× 410 6.7k
Rami Mahfouz 512 0.2× 1.0k 0.6× 1.2k 1.0× 251 0.2× 533 0.8× 200 3.5k
Shinichiro Okamoto 1.4k 0.7× 3.3k 2.0× 1.1k 0.9× 377 0.4× 1.5k 2.1× 389 7.1k

Countries citing papers authored by Vaskar Saha

Since Specialization
Citations

This map shows the geographic impact of Vaskar Saha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vaskar Saha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vaskar Saha more than expected).

Fields of papers citing papers by Vaskar Saha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vaskar Saha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vaskar Saha. The network helps show where Vaskar Saha may publish in the future.

Co-authorship network of co-authors of Vaskar Saha

This figure shows the co-authorship network connecting the top 25 collaborators of Vaskar Saha. A scholar is included among the top collaborators of Vaskar Saha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vaskar Saha. Vaskar Saha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Nandana, Gaurav Narula, Amita Trehan, et al.. (2025). Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from India. The Lancet Regional Health - Southeast Asia. 37. 100593–100593. 1 indexed citations
2.
Krishnan, Shekhar & Vaskar Saha. (2025). Global Challenges in Paediatric Acute Lymphoblastic Leukaemia. Acta Haematologica. 149(1). 39–47.
3.
Das, Nandana, Shripad Banavali, Gaurav Narula, et al.. (2024). A shorter induction corticosteroid reduces acute lymphoblastic leukaemia induction deaths in the icicle-all-14 randomised trial. SHILAP Revista de lepidopterología. 9(4). S1–S1.
4.
Moreira, Daniel C., Monika L. Metzger, Federico Antillón‐Klussmann, et al.. (2023). Development of EPAT: An assessment tool for pediatric hematology/oncology training programs. Cancer. 129(21). 3448–3456. 3 indexed citations
5.
Rennie, Stuart, Liza‐Marie Johnson, Federico Antillón, et al.. (2023). The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries. Cancer. 130(2). 173–178. 2 indexed citations
7.
Krishnan, Shekhar, et al.. (2023). Relapsed Acute Lymphoblastic Leukemia. The Indian Journal of Pediatrics. 91(2). 158–167. 7 indexed citations
8.
Johnson, Suzanne M., Clare Dempsey, Catriona Parker, et al.. (2017). Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton. Journal of Extracellular Vesicles. 6(1). 1294339–1294339. 37 indexed citations
9.
Schwab, Claire, Sarra Ryan, Lucy Chilton, et al.. (2016). EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications. Blood. 127(18). 2214–2218. 80 indexed citations
10.
Moorman, Anthony V., Julie Irving, Amir Enshaei, et al.. (2015). Composite Index for Risk Prediction in Relapsed Childhood Acute Lymphoblastic Leukaemia. Haematologica. 100. 195–196. 3 indexed citations
11.
Delft, Frederik W. van, Sharon W. Horsley, Sue Colman, et al.. (2011). Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood. 117(23). 6247–6254. 64 indexed citations
12.
Saha, Vaskar, et al.. (2011). Early imaging of a macular hole following vitrectomy with primary silicone oil tamponade. Clinical ophthalmology. 5. 1637–1637. 2 indexed citations
13.
Joel, Simon, et al.. (2007). The plasma and intracellular pharmacokinetics of clofarabine in pediatric leukemia patients. Cancer Research. 67. 1566–1566. 2 indexed citations
14.
Bury, Jonathan, et al.. (2005). LISA - a web-based trial management and decision support system for childhood acute lymphoblastic leukaemia. British Journal of Haematology. 129. 2 indexed citations
15.
Delft, Frederik W. van, Anthony Bellotti, Naina Patel, et al.. (2003). Gene expression profiling in childhood acute leukaemia; a useful classification tool and a first promising insight into drug resistance.. Blood. 102(11). 1 indexed citations
16.
Patel, Tulsi, et al.. (2003). Hierarchical clustering analysis of gene expression profiles accurately identifies subtypes of acute childhood leukaemia. British Journal of Cancer. 88. 1 indexed citations
17.
Hurt, Chris, John Fox, Jonathan Bury, & Vaskar Saha. (2003). Computerised Advice on Drug Dosage Decisions in Childhood Leukaemia: a Method and a Safety Strategy. Research Explorer (The University of Manchester). 1 indexed citations
18.
Bury, Jonathan, et al.. (2002). LISA: A Clinical Information and Decision Support System for Childhood Acute Lymphoblastic Leukaemia. ePrints Soton (University of Southampton). 988–988. 8 indexed citations
19.
Jaju, R J, Michael Neat, Jochen Harbott, et al.. (1998). A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood AML.. Blood. 92. 2 indexed citations
20.
Saha, Vaskar, et al.. (1998). Leukaemia. Current Paediatrics. 8(2). 73–77. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026